Capillary-Venous Paired Data Collection
CaVeP-DC
1 other identifier
observational
800
0 countries
N/A
Brief Summary
Capillary-venous paired data collection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
July 3, 2023
June 1, 2023
3 years
May 22, 2023
June 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Coefficient of Variance of the difference between the lab results and the Liberty results
the coefficient of variance (CV) between the lab results and the liberty results would be compared. a lower CV value signifies a better performance of our device.
3 years
Eligibility Criteria
Patients who are currently receiving standard of care systemic anti-cancer therapy (chemotherapy, immunotherapy, endocrine and targeted therapy) for solid organ malignancy and have received at least one cycle.
You may qualify if:
- Age \>18 years old at the time of study entry
- Currently receiving standard of care systemic anti-cancer therapy (chemotherapy, immunotherapy, endocrine and targeted therapy) for solid organ malignancy and has received at least one cycle of treatment
- Scheduled to be undergoing routine venous laboratory blood tests as part of standard of care
- Can provide written informed consent
You may not qualify if:
- History of haematological malignancy
- Inadequate use and understanding of the English language, requiring a translator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Entia Ltdlead
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2023
First Posted
July 3, 2023
Study Start
September 1, 2023
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
July 3, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share
It is not planned to make individual participant data (IPD) available to other researchers.